City Therapeutics

CTY
18.1004.64% ( -0.880 )
Closed: Nov 13, 16:00:00 (EDT)

Profile

About

City Therapeutics
City Therapeutics
CTY.US

City Therapeutics, Inc. operates as a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines by engineering RNAi trigger molecules. The company develops RNAi-based medicines using engineered small interfering RNAs (siRNAs) and is building a pipeline of therapeutics targeting diseases across multiple therapeutic areas, including ophthalmologic conditions such as retinal diseases and geographic atrophy. It designs and engineers RNAi trigger molecules, such as smaller size, novel cleavage mechanisms, and tailored targeting ligands to enhance potency, specificity, and delivery to various tissue types.

Profile

Company Name
City Therapeutics, Inc.
Market
NasdaqGM
Founded
Industry
--
Fiscal Year End
--

Related Securities

Industry

Management